Recap: Applied DNA Sciences Q2 Earnings Applied DNA Sciences (NASDAQ:APDN) reported its Q2 earnings results on Thursday, May 12, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Benzinga · May 12, 2022
Applied DNA Sciences To Raise $4.2M Via Registered Direct Offering Applied DNA Sciences, Inc. (NASDAQ: APDN), a polymerase chain reaction-based DNA manufacturer, has entered into a securities purchase agreement with an institutional investor, for the purchase and sale of 1.5 million shares of common stock at a price of $2.80 per share. Benzinga · Feb 22, 2022
Looking Into Applied DNA Sciences's Return On Capital Employed Applied DNA Sciences (NASDAQ:APDN) brought in sales totaling $4.17 million during Q1 according to data provided by Benzinga Pro. However, earnings decreased 4.73%, resulting in a loss of $4.72 million. Benzinga · Feb 14, 2022